Therefore, the aim of our research was to analyze LTL as a marker of inflammation for SCA1, SCA2, and SCA3, in order to identify a potential biomarker for clinical onset and disease progression and compare our findings with our HD data. Here, ATXN3 is linked to Huntington disease.